Human epidermal growth factor receptor 3 (HER3) is a protein known to be hyper-expressed in EGFR-mutated lung cancer and a mediator of resistance to tyrosine kinase inhibitors (TKIs) [47,48]. This evidence concerns the gene EGFR and lung carcinoma.